FINWIRES · TerminalLIVE
FINWIRES

瑞银称,奥驰亚第一季度业绩超预期或将推动2026财年盈利预期修正

-- 瑞银证券表示,奥驰亚集团(Altria Group,股票代码:MO)第一季度盈利可能略微超出预期,这或许会推动全年盈利预期上调。尽管价格/产品组合疲软,且on!尼古丁袋销量下滑,但卷烟销量趋势改善和市场份额提升仍将支撑盈利。 瑞银在周二发布的研究报告中指出,可吸食烟草产品销量的改善有望帮助奥驰亚重回营收增长轨道,卷烟出货量降幅较市场预期有所收窄,且市场份额已出现初步增长迹象。 瑞银预计,可吸食烟草产品的营业收入将受益于退税等因素,但部分增长将被低价Basic品牌带来的产品组合压力以及持续投资所抵消。瑞银还预计,随着这些不利因素的缓解,价格/产品组合将从第二季度开始改善。 在无烟烟草产品方面,瑞银预测第一季度销售额将增长2.0%,on!尼古丁袋销量将达到4500万罐,其他综合收益(OCI)将下降1.7%。这意味着第一季度集团营收和其他综合收益(OCI)分别增长1.6%和0.6%,每股收益(EPS)增长2.4%至1.26美元。 该券商预计全年每股收益增长5.5%至5.72美元,并认为2026年和2027年有望加速增长。瑞银表示,目前预计不会调整业绩指引。 奥驰亚集团将于4月30日公布第一季度业绩。 瑞银维持对该公司的“买入”评级,目标价为74美元。

Price: $64.85, Change: $+0.20, Percent Change: +0.31%

Related Articles

Asia

Update: Origin Energy Reports Lower March Quarter Production; Shares Fall 3%

(Updates to add stock movement in the headline and last paragraph)Origin Energy (ASX:ORG) reported March quarter production of 164.5 petajoules, down from 167.1 petajoules a year earlier, according to a Monday filing with the Australian bourse.The company reported commodity revenue of AU$1.86 billion for the quarter, down from AU$ 2.31 billion a year ago, per the filing.Origin Energy also said its electricity sales volume increased 4% from a year earlier amid "strong growth" in business volumes driven largely by the data-center sector.The company's shares fell 3% in recent Monday trade.

$ASX:ORG
Asia

Alterity Therapeutics Secures US FDA Support for ATH434 Phase Three Program

Alterity Therapeutics (ASX:ATH) said it received positive feedback from a second type C meeting with the US Food and Drug Administration (FDA) on its planned phase three program for drug candidate ATH434, aimed at treating multiple system atrophy (MSA), according to a Monday filing with the Australian bourse.MSA is a progressive neurodegenerative disorder affecting autonomic and motor function with no approved disease-modifying therapies.The US FDA provided supportive written feedback on the program's chemistry, manufacturing, and controls, complementing earlier guidance from a separate type C meeting on clinical pharmacology and non-clinical development, the filing added.

$ASX:ATH
Asia

Xinyuan Property Management's CFO Resigns

Xinyuan Property Management Service's (HKG:1895) chief financial officer, Wang Yong, has resigned, effective April 26, according to a Monday Hong Kong bourse filing.Wang stepped down to devote more time to personal commitments, the company said.The company said the resignation will not affect its normal operations, with Wang's duties to be reallocated internally on an interim basis.Xinyuan Property Management added that it is seeking a suitable replacement for the chief financial officer role.

$HKG:1895